Cardiac valve cutting device

Information

  • Patent Grant
  • 11653947
  • Patent Number
    11,653,947
  • Date Filed
    Thursday, July 22, 2021
    3 years ago
  • Date Issued
    Tuesday, May 23, 2023
    a year ago
Abstract
An interventional device for cutting tissue at a targeted cardiac valve, such as a mitral valve. The interventional device includes a catheter having a proximal end and a distal end. A cutting mechanism is positionable at the distal end, such as by routing the cutting mechanism through the catheter to position it at the distal end. The cutting mechanism includes one or more cutting elements configured for cutting valve tissue when engaged against the tissue. A handle is coupled to the proximal end of the catheter and includes one or more controls for actuating the cutting mechanism.
Description
BACKGROUND

The mitral valve controls blood flow from the left atrium to the left ventricle of the heart, preventing blood from flowing backwards from the left ventricle into the left atrium so that it is instead forced through the aortic valve for delivery of oxygenated blood throughout the body. A properly functioning mitral valve opens and closes to enable blood flow in one direction. However, in some circumstances the mitral valve is unable to close properly, allowing blood to regurgitate back into the atrium. Such regurgitation can result in shortness of breath, fatigue, heart arrhythmias, and even heart failure.


Mitral valve regurgitation has several causes. Functional mitral valve regurgitation (FMR) is characterized by structurally normal mitral valve leaflets that are nevertheless unable to properly coapt with one another to close properly due to other structural deformations of surrounding heart structures. Other causes of mitral valve regurgitation are related to defects of the mitral valve leaflets, mitral valve annulus, or other mitral valve tissues. In some circumstances, mitral valve regurgitation is a result of infective endocarditis, blunt chest trauma, rheumatic fever, Marfan syndrome, carcinoid syndrome, or congenital defects to the structure of the heart. Other cardiac valves, in particular the tricuspid valve, can similarly fail to properly close, resulting in undesirable regurgitation.


Heart valve regurgitation is often treated by replacing the faulty valve with a replacement valve implant or by repairing the valve through an interventional procedure. In many instances, a procedure for implanting a replacement heart valve is performed on a patient that has undergone a previous repair procedure for treating the targeted valve, and the targeted valve to be replaced is already associated with an interventional implant. For example, a clip device may have been deployed at the targeted heart valve to fix or approximate leaflets of the valve to reduce regurgitation at the valve. In some circumstances, however, further degradation of the treated heart valve or other clinical circumstances can necessitate that the valve be replaced. In such cases, the previously deployed interventional implant must first be unfixed and/or extracted to prepare the site for deployment and positioning of the replacement valve. As a result, challenges can arise related to the handling of the prior implant(s) and preparation of the targeted site.


The subject matter claimed herein is not limited to embodiments that solve any disadvantages or that operate only in environments such as those described above. Rather, this background is only provided to illustrate one exemplary technology area where some embodiments described herein may be practiced.


BRIEF SUMMARY

Certain embodiments described herein are directed to interventional devices for cutting tissue at a targeted cardiac valve, such as a mitral valve. One or more embodiments described herein enable detachment and/or removal of an implanted repair device from the cardiac valve in order to prepare the valve site to subsequently receive a replacement cardiac valve or other implant, or to receive other treatment.


In some embodiments, an interventional device includes a catheter having a proximal end and a distal end. The distal end is positionable at the targeted cardiac valve. A cutting mechanism is positionable at the distal end of the catheter. The cutting mechanism includes one or more cutting elements configured to cut valve tissue when engaged against the valve tissue. In some embodiments, the interventional device also includes a handle coupled to the proximal end of the catheter. The handle includes one or more cutting controls operatively coupled to the cutting mechanism to provide selective actuation of the cutting mechanism.


In some embodiments, the catheter is configured as a steerable catheter having a steerable distal end. The catheter includes one or more control lines extending from one or more steering controls of the handle to the distal end such that adjusting the tension of the one or more control lines causes deflection of the steerable distal end.


In some embodiments, the cutting mechanism is translatable within the catheter such that it is routable through the catheter to be passed beyond the distal end of the catheter and/or to be retracted proximally into the catheter. In some embodiments, the cutting mechanism includes blades arranged in a scissor-like fashion. In some embodiments, the cutting mechanism includes a cutting element configured as a needle structure and/or includes a cutting element configured as a blade structure. In some embodiments, the cutting mechanism is operatively coupled to the one or more cutting controls via one or more cutting control lines and/or an actuator rod.


In some embodiments, the handle includes or is connected to an electrical source for powering oscillating motion of the one or more cutting elements. In some embodiments, the cutting mechanism is configured to pass radio frequency electrical current and/or thermal energy to the targeted valve to cut the targeted valve.


In some embodiments, the cutting mechanism includes a noose structure positionable around valve tissue, the noose structure being configured to be selectively tightened around valve tissue to cut the valve tissue. In certain embodiments, the noose structure is formed from a hooked wire and a snare, the snare being configured to engage with the hooked wire to complete the noose structure, wherein one or both of the hooked wire and the snare are translatable relative to the distal end of the catheter. In other embodiments, the cutting system includes a first wire and a second wire, each extending distally past the distal end of the catheter, and first and second magnets (e.g., permanent magnets or electromagnets) respectively attached to the distal ends of the first and second wires. The magnets may be coupled to one another such that the first and second wires form the noose. In some embodiments including a noose structure, the targeted leaflet tissue may be cut by mechanically tightening the noose. Alternately, the targeted leaflet may be cut by contacting the noose to the tissue and applying radio frequency electrical and/or thermal energy.


In some embodiments, the cutting system includes one or more stabilizing prongs extendable distally past the distal end of the catheter, the one or more stabilizing prongs being configured to engage against tissue at the targeted valve to stabilize the distal end of the catheter relative to the targeted valve. In some embodiments, the cutting system includes a stabilizing cup which is extendable distally past the distal end of the catheter and is configured to engage with targeted leaflet tissue. The cup may also be configured to hold an interventional device implanted into the leaflet tissue such that the interventional device may be captured and removed from the patient after the surrounding and/or adjacent leaflet tissue has been cut.


Certain embodiments are directed to methods of cutting cardiac valve tissue at a targeted cardiac valve, such as a mitral valve. In some embodiments, a method includes positioning a delivery catheter within a body so that a distal end of the delivery catheter is positioned near the targeted cardiac valve, routing a cutting mechanism through the delivery catheter so that the cutting mechanism at least partially extends distally beyond the distal end of the catheter to enable the cutting mechanism to engage with leaflet tissue of the targeted cardiac valve, and actuating the cutting mechanism to cut at least one leaflet of the approximated adjacent leaflets.


In some implementations, the targeted cardiac valve is associated with an interventional implant (such as an interventional clip) that approximates adjacent leaflets of the targeted cardiac valve. Performance of the method therefore results in the cutting mechanism detaching the interventional implant from the at least one cut leaflet. Some methods include cutting all leaflets to which the interventional implant is attached. For example, both the anterior and the posterior leaflet of a mitral valve may be cut. The excised implant may then be removed from the patient (e.g., using a stabilizing cup).


In some embodiments, the targeted cardiac valve is a mitral valve, and the at least one cut leaflet is the anterior leaflet. In some implementations, the interventional device remains attached to the posterior leaflet. The targeted cardiac valve could also be the tricuspid, aortic, or pulmonic valve, for example.


Additional features and advantages will be set forth in part in the description that follows, and in part will be obvious from the description, or may be learned by practice of the embodiments disclosed herein. The objects and advantages of the embodiments disclosed herein will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing brief summary and the following detailed description are exemplary and explanatory only and are not restrictive of the embodiments disclosed herein or as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to describe the manner in which the above-recited and other advantages and features of the invention can be obtained, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. Understanding that these drawings depict only typical embodiments of the invention and are not therefore to be considered to be limiting of its scope, the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates an exemplary delivery system that may be utilized for guiding and/or delivering a cutting mechanism to a targeted cardiac valve;



FIGS. 2A and 2B schematically illustrate a cross-sectional side view of a targeted mitral valve having an attached interventional clip device, showing cutting of one of the valve leaflets to effect detachment of the previously approximated leaflets;



FIGS. 3A through 3F illustrate an embodiment of a cutting system including a cutting mechanism configured as a scissor like structure, showing various configurations of actuation mechanisms for controlling the cutting mechanism;



FIG. 4 illustrates an embodiment of a cutting system including a cutting mechanism configured as an electrically powered blade or needle structure;



FIGS. 5A and 5B illustrate a superior view of deployment of a blade mechanism to cut a targeted valve leaflet to disengage a clip device from the remainder of the leaflet;



FIGS. 5C and 5D illustrate a superior view of deployment of a needle mechanism to cut a targeted valve leaflet to disengage a clip device from the remainder of the leaflet;



FIG. 6 illustrates an embodiment of a cutting system including a cutting mechanism configured to cut using RF energy;



FIGS. 7A through 7D illustrate an embodiment of a cutting system including a cutting mechanism configured to form a noose structure for tightening around a targeted valve leaflet to cut the leaflet;



FIGS. 8A and 8B illustrates operation of the cutting system of FIGS. 7A through 7D, showing formation of the noose structure and cutting of a valve leaflet;



FIG. 9 illustrates an embodiment of a cutting system including stabilizing prongs;



FIGS. 10A and 10B illustrate operation of the cutting system of FIG. 9, showing use of the stabilizing prongs in conjunction with a cutting mechanism to cut a valve leaflet; and



FIGS. 11A through 11D illustrate an embodiment of a cutting system including a stabilizing cup configured for stabilizing the cutting system with respect to a targeted cardiac valve and for receiving an excised interventional device;



FIGS. 12A through 12C illustrate an embodiment of a cutting system including an alternative embodiment of a stabilizing cup; and



FIGS. 13A and 13B illustrate cup closing mechanisms for cup embodiments having self-expanding properties.





DETAILED DESCRIPTION

Certain embodiments described herein are directed to interventional devices configured for cutting a cardiac valve, such as to enable removal of an implanted repair device from the cardiac valve and/or to prepare the site of the valve to subsequently receive a replacement cardiac valve or other implant. Certain embodiments are configured to route and/or deliver a cutting mechanism to a targeted cardiac valve through a transcatheter approach, such as a transfemoral, radial, or transjugular approach. Alternatively, other implementations can utilize a transapical approach for reaching the targeted cardiac valve.


Although many of the exemplary embodiments described herein are described in the context of cutting a mitral valve and releasing one or more interventional clip devices, it will be understood that similar principles may be applied to other implementations in which other implanted interventional devices are cut away from a mitral valve and/or in which one or more clips or other interventional devices are removed/cut away from another cardiac valve, such as the tricuspid valve. More generally, the exemplary embodiments described herein may be applied in other implementations involving removal of a previously implanted or deployed device from tissue.



FIG. 1 illustrates an exemplary embodiment of a delivery system 100 that may be utilized for routing a cutting mechanism to the targeted cardiac valve. The delivery system 100 includes a guide catheter 102 operatively coupled to a handle 104. The guide catheter 102 is configured to be steerable so as to enable guiding and orienting of the distal end 106 of the catheter. For example, the illustrated handle 104 includes a control 108 (e.g., dial, switch, slider, button, etc.) that can be actuated to control the curvature of the distal end 106 of the catheter 102, as indicated by arrows 110. As explained in more detail below with respect to other similar embodiments, the handle 104 can include one or more additional controls for actuating and/or adjusting one or more components of a cutting mechanism 112. The cutting mechanism 112 is illustrated generically in FIG. 1, and may represent any of the other cutting mechanism embodiments (along with corresponding controls and other associated components) described herein.


In some embodiments, the control 108 is operatively coupled to one or more control lines 114 (e.g., pull wires) extending from the handle 104 through the catheter 102 to the distal end 106 (e.g., through one or more lumens in the catheter 102). Actuation of the control 108 adjusts the tensioning of a control line 114 so as to pull the guide catheter 102 in the corresponding direction. The illustrated embodiment is shown as having a single control 108 for providing steerability in two opposing directions. Alternative embodiments may include additional controls (and associated control lines) for providing control in one or more additional directions.


The catheter 102 includes a lumen 116 through which the cutting mechanism 112 may be routed. Accordingly, the delivery system 100 may be utilized by positioning the distal end 106 near a targeted cardiac valve, and then routing the cutting mechanism 112 through the catheter 102 and out of the distal end 106 so as to position the cutting mechanism 112 at the targeted valve. Alternatively, a cutting mechanism 112 can be coupled to the distal end 106 so that it is positioned at the targeted valve as the distal end 106 reaches the targeted valve. As described previously, the delivery system 100 may be utilized in a transfemoral, transjugular, radial, or transapical approach, for example. The delivery system 100 may be utilized to guide any of the cutting mechanisms described herein, or equivalents thereof.



FIGS. 2A and 2B illustrate a targeted mitral valve having an attached interventional clip device 220, showing cutting of one of the valve leaflets (anterior leaflet 10) to effect detachment of the previously approximated leaflets. FIG. 2A illustrates the mitral valve and clip device 220 prior to leaflet cutting, and FIG. 2B illustrates the mitral valve and clip device 220 after leaflet cutting. One or more of the delivery system and/or cutting mechanism embodiments described herein may be utilized in such a procedure.


As shown, the clip device 220 is coupled to the anterior leaflet 10 and posterior leaflet 12. In many instances, an implant such as the clip device 220 will be embedded with the leaflet tissue and/or other surrounding tissues as a result of tissue ingrowth, making it difficult to extract the implant. As shown in FIG. 2B, one of the leaflets is cut (the anterior leaflet 10, in this example) in order to separate the leaflets. Such separation may be beneficial prior to deployment of a replacement valve, or to satisfy another clinical need to reverse or minimize the effects of the repair device 220. In one preferred implementation, the anterior leaflet 10 is cut so that the clip device 220 remains attached to the posterior leaflet 12. In this position, there is less risk that the clip device will interfere with functioning of the left ventricular outflow tract (LVOT).


In contrast, cutting the posterior leaflet 12 so that the clip device 220 remains on the anterior leaflet 10, can result in weighing down of the anterior leaflet 10, which in turn can lead to detrimental interference with the LVOT. However, certain applications may allow for leaving the clip device 220 on the anterior leaflet 10 with little or acceptable risk of LVOT interference and/or may involve subsequent removal/extraction of the clip device 220 from the anterior leaflet 10. Accordingly, methods in which a posterior valve is cut are also included within this disclosure.



FIG. 3A illustrates an embodiment of a cutting system having a cutting mechanism 312 that may be utilized to cut a targeted valve to unfix/detach previously approximated valve leaflets. In this embodiment, the cutting mechanism 312 is configured as a scissor-like mechanism having opposing blade cutting elements 315 for cutting tissue. In the illustrated embodiment, the cutting mechanism 312 extends through or is attached to a distal end of a catheter 302. The cutting mechanism 312 is operatively connected to a handle 304, and the handle 304 is configured to enable selective actuation of the cutting mechanism 312. For example, the handle 304 may include one or more controls 308, and at least one of such controls 308 may be operatively coupled to the cutting mechanism 312. The control 308 may be, for example, a button, switch, dial, slider, or other suitable actuation mechanism providing a user with selective control over the cutting mechanism 312.


As shown by arrow 313, the cutting system shown in FIG. 3A is also configured to allow rotational adjustment of the cutting mechanism 312 about a longitudinal axis that extends through the catheter 302. Rotational adjustment may be accomplished, for example, by rotating the handle 304, with the rotational torque from turning the handle 304 being transferred distally to the cutting mechanism 312. Additionally, or alternatively, the cutting mechanism 312 may be rotated relative to the handle 304 through actuation of a control 308 of the handle 304. The ability to rotate the cutting mechanism 312 beneficially allows an operator to properly orient the cutting mechanism 312 relative to a targeted cardiac valve or other targeted anatomy so that a desired cut may be made.


As shown in the expanded views of FIGS. 3B through 3E, the cutting mechanism 312 may be joined to one or more control lines 314 (e.g., passing through a lumen of the catheter 302) that control actuation of the cutting mechanism 312 through adjustments to the tension of the one or more control lines 314.


In one configuration, shown in FIGS. 3B and 3C, the opposing blades 315 are operatively coupled to the control line 314 such that adjusting tension (shown by arrows 310) of the control line 314 allows the blades 315 to move between the closed position shown in FIG. 3B and the open position shown in FIG. 3C. In this configuration, the application of tension to control line 314 moves the blades 315 to the open position and the release of tension moves the blades 315 to the closed position. The blades 315 may, for example, be biased toward the closed position shown in FIG. 3B. The blades 315 may be operated by applying tension to the control line 314 to move the blades 315 toward the open position shown in FIG. 3C, then releasing tension in the control line 314 to cause the blades 315 to close and provide a cutting motion.



FIGS. 3D and 3E show another configuration in which the blades 315 close through the application of tension to the control line 314 and open upon release of tension (shown by arrows 311). The blades 315 may, for example, be biased toward the open position shown in FIG. 3E. The blades 315 may be operated by releasing tension to the control line 314 to move the blades 315 toward the open position shown in FIG. 3E, then reapplying tension in the control line 314 to cause the blades 315 to close and provide a cutting motion.



FIG. 3F illustrates another embodiment in which the cutting mechanism includes a control rod 317 operatively coupled to the cutting blades 315. Translation of the control rod 317 (shown by arrows 313) provides control over opening and closing of the blades 315. In some embodiments, distal translation of the control rod 317 causes the blades 315 to open while proximal translation of the control rod 317 causes the blades 315 to close. In other embodiments, distal translation of the control rod 317 causes the blades 315 to close while proximal translation of the control rod 317 causes the blades 315 to open. One or more push rods such as control rod 317 may be used in addition to or as an alternative to the one or more control lines 314 for controlling the cutting blades 315. The control elements and configurations shown in FIGS. 3A through 3E, including the control line(s) 314, the control rod(s) 317, and their mechanical and operational relationship with the cutting mechanism, may be utilized in any of the other embodiments described herein.



FIG. 4 illustrates another embodiment of a cutting system having a cutting mechanism 412 operatively coupled to a handle 404. In this embodiment, the cutting mechanism 412 is configured as a blade, needle, or other sharp member capable of cutting through cardiac valve leaflet tissue. The illustrated cutting mechanism 412 is further configured to provide an oscillating or translating motion to enable cutting of tissue against which the cutting mechanism 412 is engaged. As shown, the handle 404 includes a power source 417, such as a battery source or other source of electricity. Power may additionally or alternatively be provided by an external source such as through electrical cable 419 (e.g., AC or DC power). The cutting mechanism 412 is thereby powered to provide an oscillating, rotating, or other cutting motion through power transmission means known in the art. For example, the cutting mechanism 412 can include or can be operatively coupled to one or more motors 421 (e.g., servomotors) or other means of converting the delivered electrical power into the mechanical work of actuating the cutting mechanism 412.


As illustrated, motor 421 can be associated with the handle 404 and connected to linkage(s) 423 extending to the cutting mechanism 412 and thereby mechanically coupling the motor 421 to the cutting mechanism 412. The motor 421 can transfer, through the linkage(s) 423, rotative (as shown by arrow 413) and/or longitudinally oscillating (as shown by arrow 410) motion. This motion powers the cutting mechanism 412 and allows it to cut through targeted cardiac tissue or other targeted tissue.



FIGS. 5A and 5B illustrate cutting of an anterior leaflet 10 to detach a clip device 520 from the anterior leaflet 10 using a cutting mechanism 512 having a blade structure, and FIGS. 5C and 5D illustrate a cutting procedure accomplished using a cutting mechanism 512b having a needle structure.



FIG. 6 illustrates another embodiment of a cutting system including a cutting mechanism 612 operatively coupled to a handle 604. In this embodiment, the cutting mechanism includes a tip 620 capable of transmitting radio frequency (RF) energy to the targeted valve leaflets in order to provide tissue cutting functionality. The tip 620 may be configured as a blade, needle, or other relatively sharp component; however, the tip structure need not necessarily be inherently sharp enough to cut targeted tissue in applications in which RF electrical current is used to provide the cutting functionality.


The illustrated handle 604 includes an RF energy source 622. The RF energy from the RF energy source 622 may be transmitted distally along the length of the catheter 602 to the tip 620 of the cutting mechanism 612. For example, the RF energy may be transmitted through a conductor 624, which may be formed as a metallic cable or other structure suitable for transmitting RF energy. The handle 604 also includes a control 608 configured to enable control of the cutting mechanism 612 and/or adjustment to the RF energy source 622 and the applied RF energy.


In an alternative embodiment, the tip 620 of the cutting mechanism 612 is configured as a heat-transmitting structure capable of transmitting sufficient thermal energy (not induced using RF electrical current) to the targeted valve tissue to ablate and cut the valve tissue. In such embodiments, the cutting mechanism 612 is thermally coupled to a source of thermal energy at the handle 604, and the thermal energy is transmitted through the length of the catheter 602 (e.g., through conductor 624) and sufficiently concentrated at the tip 620 of the cutting mechanism 612 to provide tissue cutting functionality.



FIGS. 7A through 7C illustrate another embodiment of a cutting system that may be utilized in a valve cutting procedure. In this embodiment, the cutting mechanism is configured as a noose structure 719 for wrapping around a targeted valve leaflet to enable cutting of the leaflet upon tightening of the noose structure. As shown, the cutting system includes a handle 704 and a catheter 702 extending distally from the handle 704 to a distal end 706. As shown by the progressive succession from FIG. 7A to FIG. 7C, the noose structure 719 includes a snare 716 (including a distal loop and a wire 715 extending proximally therefrom) and a wire 718 (including a hook at its distal end) that is passable through the snare 716 to form the closed noose structure 719.


The illustrated cutting system may also include a collet 722 through which both the first wire 715 and the second wire 718 pass. The collet 722 may be configured to lock onto the wires 715 and 718 and may be translatable with respect to the catheter 702. In this manner, the diameter of the exposed portion of the noose structure 719 may be adjusted by translating the collet 722 after the collet 722 has been locked to the wires 715 and 718. For example, the diameter of the noose structure 719 may be enlarged by pushing the collet 722 distally to move more of the wires 715 and 718 distally beyond the catheter 702, and may be reduced by retracting the collet 722 proximally to pull more of the wires 715 and 718 within the catheter 702.


Although the illustrated collet 722 is shown as being disposed within the catheter 702, alternative embodiments position the collet 722 further proximally, such as at the handle 704. In some embodiments, the collet 722 and/or wires 715, 718 may be operatively coupled to a control 708 disposed at the handle 704, with the wires 715 and 718 extending proximally to the control 708 at the handle 704. As with other embodiments described herein, the control 708 may be configured as a button.



FIG. 7D illustrates an alternative configuration in which the noose structure 719 includes a first magnet 721 and second magnet 723 attached at the distal ends of respective wires 715 and 718. The magnets 721 and 723 may independently be electromagnets (e.g., powered by power source 717) or permanent magnets. The magnets 721 and 723 are configured to attract and magnetically couple to one another to form the noose structure 719.



FIGS. 8A and 8B illustrate use of the noose structure 719 shown in FIGS. 7A through 7D to cut a targeted cardiac valve leaflet 10. As shown in FIG. 8A, the noose structure 719 may first be positioned around the targeted leaflet 10. This may be accomplished by positioning the distal end 706 of the catheter 702 near the targeted leaflet 10, and then forming the noose structure 719 around the leaflet 10 by extending the wires 715 and 718 (see FIGS. 7A through 7D) around opposite sides of the leaflet 10. After the noose structure 719 has been formed around the targeted leaflet 10, the leaflet may be cut by mechanically tightening the noose structure 719 such that the noose structure 719 cuts into the tissue. Alternatively, the leaflet 10 may be cut by tightening the noose structure 719 to bring it into contact with the targeted leaflet 10 and then applying radio frequency electrical and/or thermal energy to the noose structure 719 (e.g., using RF and/or thermal energy source 722 as shown in FIGS. 7A through 7D). In FIG. 8B, the leaflet 10 is shown having been cut so as to separate the clip device 720 from the leaflet.



FIG. 9 illustrates an embodiment of a cutting system that includes a plurality of stability components which may be utilized to engage with or against tissue at or near the targeted valve. The stabilizing prongs 824 and associated components may be included in other cutting system embodiments described herein, including the embodiments shown in FIG. 1 and FIGS. 3A through 8B.


In the illustrated embodiment, a pair of prongs 824 extend distally from a distal end 806 of the catheter 802 along with the cutting mechanism 812. Other embodiments may include a different number of prongs (e.g., three, four, or more). Similar to other embodiments described above, the cutting mechanism 812 may be controlled using one or more control elements operatively coupled to the cutting mechanism 812 and to a control 808 of the handle 804. As with the cutting mechanism 812, the prongs 824 may be controllable via one or more controls 809 of the handle 804, such as by adjusting the tension in one or more control lines 814 extending through the catheter 802 to the prongs 824, through the translation of an actuator rod or catheter relative to the prongs 824, and/or through another control mechanism that operatively connects the handle 804 to the prongs 824. In some embodiments, the prongs 824 may be replaced by or may be used in conjunction with a stabilizing cup (see FIGS. 11A through 13B).


The described stabilization components may be utilized in conjunction with one or more components of any of the other cutting mechanism embodiments described herein in order to stabilize the position of the distal end 806 of the catheter 802 relative to the targeted valve tissue. For example, FIG. 10A illustrates engagement of the prongs 824 against a targeted leaflet 10 to stabilize position of the blade 812 relative to the leaflet 10. The blade 812 and/or prongs 824 may then be actuated to move the blade 812 across the leaflet 10. FIG. 10B illustrates the cut leaflet and the separated clip device 820.


Embodiments described herein are described in the context of cutting leaflet tissue around a single deployed clip device, such as by cutting a single leaflet in a mitral valve (preferably the anterior leaflet). In other implementations, both leaflets may be cut so as to completely free the clip device. In such applications, prongs (such as the prongs 824 illustrated in FIG. 9) and/or a cup (such as the cup 926 or 1026 illustrated in FIGS. 11A through 13B) may be utilized to grasp the clip device as it is cut free. The extracted clip device may then be removed by retracting the prongs and/or cup through the catheter, carrying the extracted clip device away from the targeted valve. Additionally, or alternatively, a vacuum may be applied to the catheter (such as by applying suction at the proximal end and/or handle) to enable the extracted clip device to be pulled into the catheter and removed.



FIGS. 11A through 11D illustrates an embodiment of a cutting system having a catheter 902 extending distally from a handle (not shown; see, e.g., FIG. 1), a cutting mechanism 912 that extends through or is attached to a distal end of the catheter 902, and a stabilizing cup 926 capable of extending distally from the distal end of the catheter 902. The cutting mechanism 912 is shown here in generic form as a dashed line, and cutting mechanism 912 therefore represents any of the cutting mechanism embodiments described herein, including the noose structure 719 of FIGS. 7A through 8B, cutting mechanism 612 of FIG. 6, cutting mechanism 512 of FIG. 5A, cutting mechanism 512b of FIG. 5C, or cutting mechanism 312 of FIGS. 3A through 3F.


In the illustrated embodiment, the cup 926 is attached to an inner member 928 which extends proximally from the cup 926 toward the handle. By advancing or retracting the inner member 928 relative to the catheter 902, the cup 926 may be respectively advanced past the distal end of the catheter 902 or retracted into the catheter 902. The inner member 928 may be formed, for example, as a hypotube, push rod, catheter, or other suitable structure capable of transmitting longitudinal movement to the cup 926.


The cup 926 may be formed as an expandable structure capable of moving between a collapsed, lower profile configuration and an expanded, fully open configuration. For example, the cup 926 may be biased toward the expanded, fully open position such that when the cup 926 is advanced past the distal end of the catheter 902 (and/or the catheter 902 is retracted to expose the cup 926) the cup 926 self-expands from the collapsed configuration to the open, expanded position. As shown in FIG. 11A, as the cup 926 is advanced relative to the catheter 902, the distal-most portion of the cup 926 begins to open and expand, while the more proximal portion remaining within the lumen of the catheter 902 remains in a collapsed configuration. In some embodiments, the cup 926 includes a frame structure made of a suitable self-expanding material, such as nitinol. The frame structure may also be covered in a membrane (e.g., formed from a suitable medical-grade polymer) to further define the shape of the cup 926.


As shown in FIG. 11B, the cup 926 is configured to contact and cup the implanted interventional device 920 and/or leaflet tissue adjacent the implanted interventional device 920. In procedures where the interventional device 920 is completely cut free from the targeted cardiac valve 10 (e.g., where both leaflets of the mitral valve are cut), the cup 926 can function to hold and receive the excised interventional device 920. In the illustrated embodiment, the cup 926 is coupled to an adjustment wire 932 which extends proximally to the handle (e.g., through the inner member 928). The application and release of tension in the adjustment wire 932 causes the cup 926 to tighten and loosen, respectively, around the targeted valve 10. For example, the adjustment wire 932 may wrap around the periphery 934 of the cup 926 such that the application of tension to the adjustment wire 932 causes the periphery 934 of the cup 926 to “cinch” to a smaller diameter. For purposes of clarity, FIGS. 11B and 11C illustrate the cup 926 with a somewhat loose grasp to the targeted valve 10, it will be understood that the cup 926 may be adjusted to a desired fit or tightness against the targeted valve 10.


In preferred embodiments, the catheter 902 is a multi-lumen catheter including a lumen for the cutting mechanism 912 and a separate lumen for the cup 926 and inner member 928. Alternatively, the catheter 902 may be a single-lumen catheter. In such a single-lumen catheter embodiment, the cutting system may additionally include a tether 936 coupling the cup 926 to the cutting mechanism 912, as shown in FIG. 11B. For example, in a single-lumen catheter embodiment, the cup 926 may be deployed first, then detached from the inner member 928. The cutting mechanism 912 may then be deployed to cut the valve 10. The tether 936 maintains connection of the cutting system to the cup 926.


As shown in FIG. 11C, after the cutting mechanism 912 has cut the targeted valve 10, the cup 926 remains in contact with the cut portion of the leaflet tissue which includes the excised interventional device 920. As shown in FIG. 11D, the cup 926 may then be retracted into the catheter 902 to allow the excised interventional device 920 to be withdrawn from the patient. The cup 926 may be included with other cutting system embodiments described herein, including the embodiments shown in FIGS. 1 and 3A through 10B.



FIGS. 12A through 12C illustrate an alternative embodiment of a cutting system including a catheter 1002 (shown here as a multi-lumen catheter), cutting mechanism 1012, inner member 1028, and cup 1026. The cutting system shown in FIGS. 12A through 12C may be configured similar to the cutting system of FIGS. 11A through 11D. However, whereas the cup 926 is oriented to open in a direction transverse to the longitudinal axis of the catheter 902, the cup 1026 is oriented to open in a direction substantially aligned with the longitudinal axis of the catheter 1002. FIG. 12A illustrates that the interventional device 1020 and surrounding tissue is grasped within the cup 1026 as the valve 10 is cut by the cutting mechanism 1012, FIG. 12B illustrates the excised interventional device 1020 held within the cup 1026 after the valve 10 has been cut, and FIG. 12C illustrates tightening and/or “cinching” of the cup 1026 to more fully hold the excised interventional device 1020. After receiving the excised interventional device 1020, the cup 1026 may be retracted into the catheter 1002 and the system removed from the patient.



FIGS. 13A and 13B further illustrate closing mechanics related to the cup 926 of FIGS. 11A through 11D and the cup 1026 of FIGS. 12A through 12C, respectively. FIG. 13A illustrates a cross-sectional view of the distal portion of the catheter 902, showing the opening/rim of the cup 926. As the inner member 928 is retracted relative to the catheter 902, the cup 926 is brought into contact against the distal end of the catheter 902. The peripheral curvature of the cup 926 at the point where the cup 926 abuts the catheter 902 allows the cup 926 to collapse into a more oblong and lower profile shape as it is forced against the distal end of the catheter 902. Further proximal retraction of the inner member 928 forces the cup 926 to a correspondingly lower profile until it can be retracted fully within the catheter 902. In the illustrated embodiment, the frame of the cup 926 may include one or more pivot points 930 that aid in folding of the cup 926 toward the collapsed position. Other embodiments may omit pivot points 930 and may instead utilize inherent flexibility of the frame to allow collapse of the cup 926.



FIG. 13B illustrates a cross-sectional view of the catheter 1002 and cup 1026. Similar to the embodiment of FIG. 13A, proximal retraction of the inner member 1028 relative to the catheter 1002 brings the cup 1026 into contact against the distal end of the catheter 1002. The peripheral curvature of the cup 1026 at the point where the cup 1026 contacts the catheter 1002 allows the distal rim of the cup 1026 to collapse radially inward as the cup 1026 is forced against the distal end of the catheter 1002.


The terms “approximately,” “about,” and “substantially” as used herein represent an amount or condition close to the stated amount or condition that still performs a desired function or achieves a desired result. For example, the terms “approximately,” “about,” and “substantially” may refer to an amount or condition that deviates by less than 10%, or by less than 5%, or by less than 1%, or by less than 0.1%, or by less than 0.01% from a stated amount or condition.


Elements described in relation to any embodiment depicted and/or described herein may be combinable with elements described in relation to any other embodiment depicted and/or described herein. For example, any element described in relation to the delivery system 100 of FIG. 1, the stabilizing prongs of FIG. 9, and/or the stabilizing cups of FIGS. 11A through 13B, may be combinable with any element described in relation to any of the cutting mechanisms of FIGS. 3A through 8B. Likewise, elements of the delivery system of FIG. 1 may be utilized in any of the other cutting system embodiments described herein, elements of the stabilizing prongs of FIG. 9 may be utilized in any of the other cutting system embodiments described herein, and elements of either of the stabilizing cups of FIGS. 11A through 13B may be utilized in any of the other cutting system embodiments described herein.

Claims
  • 1. An interventional device for cutting tissue at a targeted cardiac valve, the interventional device comprising: a catheter having a proximal end and a distal end, the distal end of the catheter being positionable at the targeted cardiac valve;a cutting mechanism positionable at the distal end of the catheter, the cutting mechanism including a noose structure positionable around leaflet tissue of the targeted cardiac valve to enable cutting of the leaflet tissue;a handle coupled to the proximal end of the catheter, the handle including one or more cutting controls operatively coupled to the cutting mechanism to provide selective actuation of the cutting mechanism; anda collet operatively coupled to the noose structure, the collet being longitudinally translatable within the catheter to enable selective adjustment of size of the noose structure,wherein the cutting mechanism includes a first wire and a second wire, a first magnet being coupled to a distal end of the first wire and a second magnet being coupled to a distal end of the second wire, the first and second magnets being configured to couple with one another to form the noose structure.
  • 2. The interventional device of claim 1, wherein the noose structure is configured to be selectively adjusted in diameter to enable tightening of the noose structure around the leaflet tissue.
  • 3. The interventional device of claim 1, wherein the noose structure is configured to provide radio frequency electrical current and/or thermal energy to the targeted valve to enable cutting of the leaflet tissue.
  • 4. The interventional device of claim 1, wherein the cutting mechanism includes a hook and a snare, the snare being configured to engage with the hook to form the noose structure, wherein one or both of the hook and the snare are translatable relative to the distal end of the catheter.
  • 5. The interventional device of claim 4, wherein the snare is coupled to a first wire and the hook is coupled to a second wire, the first and second wires extending proximally through the catheter to the handle.
  • 6. A method of cutting cardiac valve tissue at a targeted cardiac valve within a body, the method comprising: positioning a catheter within a body so that a distal end of the catheter is positioned near the targeted cardiac valve and an interventional implant that approximates adjacent leaflets of the targeted cardiac valve, the catheter having a distal end that is positionable at the targeted cardiac valve;extending a cutting mechanism at least partially distally beyond the distal end of the catheter to enable the cutting mechanism to engage with leaflet tissue of the targeted cardiac valve, the cutting mechanism comprising a noose structure positionable around leaflet tissue of the targeted cardiac valve to enable cutting of the leaflet tissue, the noose structure being operatively coupled to one or more cutting controls disposed at a handle, the cutting mechanism includes a first wire and a second wire, a first magnet being coupled to a distal end of the first wire and a second magnet being coupled to a distal end of the second wire, the first and second magnets being configured to couple with one another to form the noose structure, the handle is coupled to the proximal end of the catheter and includes one or more cutting controls operatively coupled to the cutting mechanism to provide selective actuation of the cutting mechanism, and a collet is operatively coupled to the noose structure and is longitudinally translatable within the catheter to enable selective adjustment of size of the noose structure; andactuating the cutting mechanism to cut at least one leaflet of the approximated adjacent leaflets, the cutting mechanism thereby detaching the interventional implant from the at least one cut leaflet.
  • 7. The method of claim 6, wherein the targeted cardiac valve is a mitral valve having an anterior leaflet and a posterior leaflet.
  • 8. The method of claim 7, wherein the at least one cut leaflet is the anterior leaflet, the interventional implant remaining attached to the posterior leaflet.
  • 9. The method of claim 7, wherein both the anterior leaflet and the posterior leaflet are cut, the method further comprising removing the interventional implant from the body after it is extracted from the mitral valve.
  • 10. The method of claim 6, wherein the interventional implant is an interventional clip previously implanted at the mitral valve.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 15/724,545, filed Oct. 4, 2017, titled “Cardiac Valve Cutting Device,” which claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/404,558, filed Oct. 5, 2016, titled “Cardiac Valve Cutting Device,” the disclosure of which is incorporated herein by this reference in its entirety.

US Referenced Citations (678)
Number Name Date Kind
1996261 Storz Apr 1935 A
2097018 Chamberlin Oct 1937 A
2108206 Mecker Feb 1938 A
3296668 Aiken Jan 1967 A
3378010 Codling et al. Apr 1968 A
3470875 Johnson Oct 1969 A
3557780 Sato Jan 1971 A
3671979 Moulopoulos Jun 1972 A
3675639 Cimber Jul 1972 A
3874338 Happel Apr 1975 A
3874388 King et al. Apr 1975 A
4007743 Blake Feb 1977 A
4056854 Boretos et al. Nov 1977 A
4064881 Meredith Dec 1977 A
4091815 Larsen May 1978 A
4112951 Hulka et al. Sep 1978 A
4235238 Ogiu et al. Nov 1980 A
4297749 Davis et al. Nov 1981 A
4312337 Donohue Jan 1982 A
4425908 Simon Jan 1984 A
4458682 Cerwin Jul 1984 A
4484579 Meno et al. Nov 1984 A
4487205 Di et al. Dec 1984 A
4498476 Cerwin et al. Feb 1985 A
4510934 Batra Apr 1985 A
4531522 Bedi et al. Jul 1985 A
4578061 Lemelson Mar 1986 A
4641366 Yokoyama et al. Feb 1987 A
4686965 Bonnet et al. Aug 1987 A
4777951 Cribier et al. Oct 1988 A
4809695 Gwathmey et al. Mar 1989 A
4872455 Pinchuk et al. Oct 1989 A
4878495 Grayzel Nov 1989 A
4917089 Sideris Apr 1990 A
4944295 Gwathmey et al. Jul 1990 A
4969890 Sugita et al. Nov 1990 A
4994077 Dobben Feb 1991 A
5015249 Nakao et al. May 1991 A
5019096 Fox et al. May 1991 A
5042707 Taheri Aug 1991 A
5047041 Samuels Sep 1991 A
5049153 Nakao et al. Sep 1991 A
5053043 Gottesman et al. Oct 1991 A
5061277 Carpentier et al. Oct 1991 A
5069679 Taheri Dec 1991 A
5071428 Chin et al. Dec 1991 A
5078722 Stevens Jan 1992 A
5078723 Dance et al. Jan 1992 A
5108368 Hammerslag et al. Apr 1992 A
5125758 Dewan Jun 1992 A
5171252 Friedland Dec 1992 A
5171259 Inoue Dec 1992 A
5190554 Coddington et al. Mar 1993 A
5195968 Lundquist et al. Mar 1993 A
5209756 Seedhom et al. May 1993 A
5217460 Knoepfler Jun 1993 A
5226429 Kuzmak Jul 1993 A
5226911 Chee et al. Jul 1993 A
5234437 Sepetka Aug 1993 A
5242456 Nash et al. Sep 1993 A
5250071 Palermo Oct 1993 A
5251611 Zehel et al. Oct 1993 A
5254130 Poncet et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5271381 Ailinger et al. Dec 1993 A
5275578 Adams Jan 1994 A
5282845 Bush et al. Feb 1994 A
5304131 Paskar Apr 1994 A
5306283 Conners Apr 1994 A
5306286 Stack et al. Apr 1994 A
5312415 Palermo May 1994 A
5314424 Nicholas May 1994 A
5318525 West et al. Jun 1994 A
5320632 Heidmueller Jun 1994 A
5325845 Adair Jul 1994 A
5330442 Green et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5336227 Nakao et al. Aug 1994 A
5342393 Stack Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5359994 Krauter et al. Nov 1994 A
5368564 Savage Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5383886 Kensey et al. Jan 1995 A
5387219 Rappe Feb 1995 A
5391182 Chin Feb 1995 A
5403312 Yates et al. Apr 1995 A
5403326 Harrison et al. Apr 1995 A
5411552 Andersen et al. May 1995 A
5417684 Jackson May 1995 A
5417699 Klein et al. May 1995 A
5417700 Egan May 1995 A
5423830 Schneebaum et al. Jun 1995 A
5423857 Rosenman et al. Jun 1995 A
5423858 Bolanos et al. Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5431666 Sauer et al. Jul 1995 A
5437551 Chalifoux Aug 1995 A
5437681 Meade et al. Aug 1995 A
5447966 Hermes et al. Sep 1995 A
5450860 O'Connor Sep 1995 A
5456400 Shichman et al. Oct 1995 A
5456684 Schmidt et al. Oct 1995 A
5462527 Stevens-Wright et al. Oct 1995 A
5472044 Hall et al. Dec 1995 A
5472423 Gronauer Dec 1995 A
5476470 Fitzgibbons, Jr. Dec 1995 A
5477856 Lundquist Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5487746 Yu et al. Jan 1996 A
5496332 Sierra et al. Mar 1996 A
5507725 Savage et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5520701 Lerch May 1996 A
5522873 Jackman et al. Jun 1996 A
5527313 Scott et al. Jun 1996 A
5527321 Hinchliffe Jun 1996 A
5527322 Klein et al. Jun 1996 A
5536251 Evard et al. Jul 1996 A
5540705 Meade et al. Jul 1996 A
5542949 Yoon Aug 1996 A
5554185 Block et al. Sep 1996 A
5562678 Booker Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5571085 Accisano, III Nov 1996 A
5571137 Marlow et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5575802 McQuilkin et al. Nov 1996 A
5582611 Tsuruta et al. Dec 1996 A
5584803 Stevens et al. Dec 1996 A
5593424 Northrup, III Jan 1997 A
5593435 Carpentier et al. Jan 1997 A
5609598 Laufer et al. Mar 1997 A
5617854 Munsif Apr 1997 A
5618306 Roth et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5620461 Muijs et al. Apr 1997 A
5626588 Sauer et al. May 1997 A
5634932 Schmidt Jun 1997 A
5636634 Kordis et al. Jun 1997 A
5639277 Mariant et al. Jun 1997 A
5640955 Ockuly et al. Jun 1997 A
5649937 Bito et al. Jul 1997 A
5662681 Nash et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5669919 Sanders et al. Sep 1997 A
5690671 McGurk et al. Nov 1997 A
5695504 Gifford et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5702825 Keita et al. Dec 1997 A
5706824 Whittier Jan 1998 A
5709707 Lock et al. Jan 1998 A
5713910 Gordon et al. Feb 1998 A
5713911 Racenet et al. Feb 1998 A
5715817 Stevens-Wright et al. Feb 1998 A
5716367 Koike et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5719725 Nakao Feb 1998 A
5722421 Francese et al. Mar 1998 A
5725542 Yoon Mar 1998 A
5725556 Moser et al. Mar 1998 A
5738649 Macoviak Apr 1998 A
5741271 Nakao Apr 1998 A
5741280 Fleenor Apr 1998 A
5746747 McKeating May 1998 A
5749828 Yeung May 1998 A
5759193 Burbank et al. Jun 1998 A
5769812 Stevens et al. Jun 1998 A
5769863 Garrison Jun 1998 A
5772578 Heimberger et al. Jun 1998 A
5782845 Shewchuk Jul 1998 A
5797927 Yoon Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810847 Laufer et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810853 Yoon Sep 1998 A
5810876 Kelleher Sep 1998 A
5814029 Hassett Sep 1998 A
5820591 Thompson et al. Oct 1998 A
5820592 Hammerslag Oct 1998 A
5820630 Lind Oct 1998 A
5820631 Nobles Oct 1998 A
5823955 Kuck et al. Oct 1998 A
5823956 Roth et al. Oct 1998 A
5824065 Gross Oct 1998 A
5827237 Macoviak et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5833671 Macoviak et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5843031 Hermann et al. Dec 1998 A
5843103 Wulfman Dec 1998 A
5849019 Yoon Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855271 Eubanks et al. Jan 1999 A
5855590 Malecki et al. Jan 1999 A
5855614 Stevens et al. Jan 1999 A
5860990 Nobles et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5868733 Ockuly et al. Feb 1999 A
5876399 Chia et al. Mar 1999 A
5879307 Chio et al. Mar 1999 A
5885271 Hamilton et al. Mar 1999 A
5891160 Williamson et al. Apr 1999 A
5895404 Ruiz Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5906620 Nakao May 1999 A
5908420 Parins et al. Jun 1999 A
5916147 Boury Jun 1999 A
5928224 Laufer Jul 1999 A
5944733 Engelson Aug 1999 A
5947363 Bolduc et al. Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5957973 Quiachon et al. Sep 1999 A
5972020 Carpentier et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5980455 Daniel et al. Nov 1999 A
5989284 Laufer Nov 1999 A
5997547 Nakao Dec 1999 A
6007546 Snow Dec 1999 A
6015417 Reynolds, Jr. Jan 2000 A
6019722 Spence et al. Feb 2000 A
6022360 Reimels et al. Feb 2000 A
6033378 Lundquist et al. Mar 2000 A
6036699 Andreas et al. Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6056769 Epstein et al. May 2000 A
6059757 Macoviak et al. May 2000 A
6060628 Aoyama et al. May 2000 A
6060629 Pham et al. May 2000 A
6063106 Gibson May 2000 A
6066146 Carroll et al. May 2000 A
6068628 Fanton et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6077214 Mortier et al. Jun 2000 A
6086600 Kortenbach Jul 2000 A
6088889 Luther et al. Jul 2000 A
6090118 McGuckin, Jr. Jul 2000 A
6099505 Ryan et al. Aug 2000 A
6099553 Hart et al. Aug 2000 A
6110145 Macoviak Aug 2000 A
6117144 Nobles et al. Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6123665 Kawano Sep 2000 A
6123699 Webster, Jr. Sep 2000 A
6126658 Baker Oct 2000 A
6132447 Dorsey Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6139508 Simpson et al. Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6162233 Williamson et al. Dec 2000 A
6165164 Hill et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6171320 Monassevitch Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6180059 Divino et al. Jan 2001 B1
6182664 Cosgrove Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190408 Melvin Feb 2001 B1
6197043 Davidson Mar 2001 B1
6203531 Ockuly et al. Mar 2001 B1
6203553 Robertson et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6210419 Mayenberger et al. Apr 2001 B1
6210432 Solem et al. Apr 2001 B1
6245079 Nobles et al. Jun 2001 B1
6267746 Bumbalough Jul 2001 B1
6267781 Tu Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6277555 Duran et al. Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6283962 Tu et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6306133 Tu et al. Oct 2001 B1
6312447 Grimes Nov 2001 B1
6319250 Falwell et al. Nov 2001 B1
6322559 Daulton et al. Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6352708 Duran et al. Mar 2002 B1
6355030 Aldrich et al. Mar 2002 B1
6358277 Duran Mar 2002 B1
6368326 Dakin et al. Apr 2002 B1
6387104 Pugsley et al. May 2002 B1
6402780 Williamson et al. Jun 2002 B2
6402781 Langberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6419640 Taylor Jul 2002 B1
6419669 Frazier et al. Jul 2002 B1
6461366 Seguin Oct 2002 B1
6464707 Bjerken Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6508828 Akerfeldt et al. Jan 2003 B1
6517550 Konya et al. Feb 2003 B1
6533796 Sauer et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6540755 Ockuly et al. Apr 2003 B2
6551331 Nobles et al. Apr 2003 B2
6562037 Paton et al. May 2003 B2
6562052 Nobles et al. May 2003 B2
6575971 Hauck et al. Jun 2003 B2
6585761 Taheri Jul 2003 B2
6599311 Biggs et al. Jul 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6629534 St et al. Oct 2003 B1
6641592 Sauer et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6669687 Saadat Dec 2003 B1
6685648 Flaherty et al. Feb 2004 B2
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6701929 Hussein Mar 2004 B2
6702825 Frazier et al. Mar 2004 B2
6702826 Liddicoat et al. Mar 2004 B2
6709382 Horner Mar 2004 B1
6709456 Langberg et al. Mar 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6719767 Kimblad Apr 2004 B1
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6740107 Loeb et al. May 2004 B2
6746471 Mortier et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755777 Schweich et al. Jun 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6767349 Ouchi Jul 2004 B2
6770083 Seguin Aug 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6860179 Hopper et al. Mar 2005 B2
6875224 Grimes Apr 2005 B2
6926715 Hauck et al. Aug 2005 B1
6932810 Ryan Aug 2005 B2
6945978 Hyde Sep 2005 B1
6949122 Adams et al. Sep 2005 B2
6966914 Abe Nov 2005 B2
6986775 Morales et al. Jan 2006 B2
7004970 Cauthen et al. Feb 2006 B2
7011669 Kimblad Mar 2006 B2
7033390 Johnson et al. Apr 2006 B2
7048754 Martin et al. May 2006 B2
7112207 Allen et al. Sep 2006 B2
7226467 Lucatero et al. Jun 2007 B2
7288097 Seguin Oct 2007 B2
7291168 Macoviak et al. Nov 2007 B2
7338467 Lutter Mar 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7435257 Lashinski et al. Oct 2008 B2
7464712 Oz et al. Dec 2008 B2
7497822 Kugler et al. Mar 2009 B1
7533790 Knodel et al. May 2009 B1
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7635329 Goldfarb et al. Dec 2009 B2
7651502 Jackson Jan 2010 B2
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7955340 Michlitsch et al. Jun 2011 B2
8216234 Long Jul 2012 B2
8257356 Bleich et al. Sep 2012 B2
8398708 Meiri et al. Mar 2013 B2
8435237 Bahney May 2013 B2
8500768 Cohen Aug 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8623077 Cohn Jan 2014 B2
8690858 Machold et al. Apr 2014 B2
8821518 Saliman et al. Sep 2014 B2
8926588 Berthiaume et al. Jan 2015 B2
9126032 Khairkhahan et al. Sep 2015 B2
9211119 Hendricksen et al. Dec 2015 B2
9370341 Ceniccola Jun 2016 B2
9498331 Chang et al. Nov 2016 B2
9572666 Basude et al. Feb 2017 B2
9770256 Cohen et al. Sep 2017 B2
9949833 McCleary et al. Apr 2018 B2
10667804 Basude et al. Jun 2020 B2
11013554 Coates May 2021 B2
11406250 Saadat et al. Aug 2022 B2
20010002445 Vesely May 2001 A1
20010004715 Duran et al. Jun 2001 A1
20010005787 Oz et al. Jun 2001 A1
20010010005 Kammerer et al. Jul 2001 A1
20010018611 Solem et al. Aug 2001 A1
20010022872 Marui Sep 2001 A1
20010037084 Nardeo Nov 2001 A1
20010039411 Johansson et al. Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20010044635 Niizeki et al. Nov 2001 A1
20020013547 Paskar Jan 2002 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020022848 Garrison et al. Feb 2002 A1
20020026233 Shaknovich Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020035381 Bardy et al. Mar 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020055767 Forde et al. May 2002 A1
20020055774 Liddicoat May 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020058910 Hermann et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020077687 Ahn Jun 2002 A1
20020087148 Brock et al. Jul 2002 A1
20020087169 Brock et al. Jul 2002 A1
20020087173 Alferness et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020107534 Schaefer et al. Aug 2002 A1
20020147456 Diduch et al. Oct 2002 A1
20020156526 Hlavka et al. Oct 2002 A1
20020158528 Tsuzaki et al. Oct 2002 A1
20020161378 Downing Oct 2002 A1
20020169360 Taylor et al. Nov 2002 A1
20020173811 Tu et al. Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020183766 Seguin Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20030005797 Hopper et al. Jan 2003 A1
20030045778 Online et al. Mar 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030069570 Witzel et al. Apr 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030069636 Solem et al. Apr 2003 A1
20030074012 Nguyen et al. Apr 2003 A1
20030078654 Taylor et al. Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030105520 Alferness et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030120341 Shennib et al. Jun 2003 A1
20030130669 Damarati Jul 2003 A1
20030130730 Cohn et al. Jul 2003 A1
20030144697 Mathis et al. Jul 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030171776 Adams et al. Sep 2003 A1
20030187467 Schreck Oct 2003 A1
20030195562 Collier et al. Oct 2003 A1
20030208231 Williamson et al. Nov 2003 A1
20030229395 Cox Dec 2003 A1
20030233038 Hassett Dec 2003 A1
20040002719 Oz et al. Jan 2004 A1
20040003819 St et al. Jan 2004 A1
20040015232 Shu et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024414 Downing Feb 2004 A1
20040030382 St et al. Feb 2004 A1
20040039442 St et al. Feb 2004 A1
20040039443 Solem et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040059345 Nakao Mar 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040078053 Berg et al. Apr 2004 A1
20040087975 Lucatero et al. May 2004 A1
20040088047 Spence et al. May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040097878 Anderson et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040106989 Wilson et al. Jun 2004 A1
20040111099 Nguyen et al. Jun 2004 A1
20040116848 Gardeski et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040127849 Kantor Jul 2004 A1
20040127981 Rahdert et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133062 Pai et al. Jul 2004 A1
20040133063 McCarthy et al. Jul 2004 A1
20040133082 Abraham-Fuchs et al. Jul 2004 A1
20040133192 Houser et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133232 Rosenbluth et al. Jul 2004 A1
20040133240 Adams et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040147826 Peterson Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040152847 Emri et al. Aug 2004 A1
20040152947 Schroeder et al. Aug 2004 A1
20040153144 Seguin Aug 2004 A1
20040158123 Jayaraman Aug 2004 A1
20040162610 Liska et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040186486 Roue et al. Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040220593 Greenhalgh Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040225233 Frankowski et al. Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040225305 Ewers et al. Nov 2004 A1
20040236354 Seguin Nov 2004 A1
20040242960 Orban, III Dec 2004 A1
20040243229 Vidlund et al. Dec 2004 A1
20040249452 Adams et al. Dec 2004 A1
20040249453 Cartledge et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20050004583 Oz et al. Jan 2005 A1
20050004665 Aklog Jan 2005 A1
20050004668 Aklog et al. Jan 2005 A1
20050021056 St et al. Jan 2005 A1
20050021057 St et al. Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050038383 Kelley et al. Feb 2005 A1
20050038508 Gabbay Feb 2005 A1
20050049698 Bolling et al. Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050059351 Cauwels et al. Mar 2005 A1
20050065453 Shabaz et al. Mar 2005 A1
20050085903 Lau Apr 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050159763 Mollenauer et al. Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050192633 Montpetit Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050228422 Machold et al. Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050251001 Hassett Nov 2005 A1
20050256452 Demarchi et al. Nov 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050273160 Lashinski et al. Dec 2005 A1
20050277876 Hayden Dec 2005 A1
20050287493 Novak et al. Dec 2005 A1
20060004247 Kute et al. Jan 2006 A1
20060009759 Chrisitian et al. Jan 2006 A1
20060015003 Moaddes et al. Jan 2006 A1
20060015179 Bulman-Fleming et al. Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060030866 Schreck Feb 2006 A1
20060030867 Zadno Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060064116 Allen et al. Mar 2006 A1
20060064118 Kimblad Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060089671 Goldfarb et al. Apr 2006 A1
20060089711 Dolan Apr 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060135993 Seguin Jun 2006 A1
20060184198 Bales et al. Aug 2006 A1
20060184203 Martin et al. Aug 2006 A1
20060195012 Mortier et al. Aug 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060252984 Rahdert et al. Nov 2006 A1
20060276890 Solem et al. Dec 2006 A1
20070016225 Nakao Jan 2007 A1
20070038293 St et al. Feb 2007 A1
20070060997 De Boer Mar 2007 A1
20070100356 Lucatero et al. May 2007 A1
20070118155 Goldfarb et al. May 2007 A1
20070129737 Goldfarb et al. Jun 2007 A1
20070173757 Levine et al. Jul 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070260225 Sakakine et al. Nov 2007 A1
20070287884 Schena Dec 2007 A1
20080009858 Rizvi Jan 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080045936 Vaska et al. Feb 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080051807 St et al. Feb 2008 A1
20080097467 Gruber et al. Apr 2008 A1
20080097489 Goldfarb et al. Apr 2008 A1
20080167714 St et al. Jul 2008 A1
20080183194 Goldfarb et al. Jul 2008 A1
20080188850 Mody et al. Aug 2008 A1
20080195126 Solem Aug 2008 A1
20080243249 Kohm et al. Oct 2008 A1
20080294175 Bardsley et al. Nov 2008 A1
20080312496 Zwolinski Dec 2008 A1
20090012538 Saliman et al. Jan 2009 A1
20090036768 Seehusen et al. Feb 2009 A1
20090156995 Martin et al. Jun 2009 A1
20090163934 Raschdorf et al. Jun 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090192510 Bahney Jul 2009 A1
20090198322 Deem et al. Aug 2009 A1
20090204005 Keast et al. Aug 2009 A1
20090209955 Forster et al. Aug 2009 A1
20090209991 Hinchliffe et al. Aug 2009 A1
20090270858 Hauck et al. Oct 2009 A1
20090276039 Meretei Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090326567 Goldfarb et al. Dec 2009 A1
20100016958 St et al. Jan 2010 A1
20100022823 Goldfarb et al. Jan 2010 A1
20100044410 Argentine et al. Feb 2010 A1
20100121437 Subramanian et al. May 2010 A1
20100152612 Headley, Jr Jun 2010 A1
20100217261 Watson Aug 2010 A1
20100262231 Tuval et al. Oct 2010 A1
20100268226 Epp et al. Oct 2010 A1
20100298929 Thornton et al. Nov 2010 A1
20110009864 Bucciaglia et al. Jan 2011 A1
20110184405 Mueller Jul 2011 A1
20110224710 Bleich Sep 2011 A1
20110238052 Robinson Sep 2011 A1
20120022527 Woodruff et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120150194 Odermatt et al. Jun 2012 A1
20120172915 Fifer et al. Jul 2012 A1
20120179184 Orlov Jul 2012 A1
20120265222 Gordin et al. Oct 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120316639 Kleinschrodt Dec 2012 A1
20120330348 Strauss et al. Dec 2012 A1
20130041314 Dillon Feb 2013 A1
20130066341 Ketai et al. Mar 2013 A1
20130066342 Dell et al. Mar 2013 A1
20130109910 Alexander et al. May 2013 A1
20130172828 Kappel Jul 2013 A1
20130317515 Kuroda et al. Nov 2013 A1
20140039511 Morris et al. Feb 2014 A1
20140135799 Henderson May 2014 A1
20140228871 Cohen et al. Aug 2014 A1
20140276913 Tah et al. Sep 2014 A1
20140309670 Bakos et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140350662 Mordehay Nov 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140364866 Dryden Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20150005704 Heisel et al. Jan 2015 A1
20150005801 Marquis et al. Jan 2015 A1
20150051698 Ruyra et al. Feb 2015 A1
20150094800 Chawla Apr 2015 A1
20150112430 Creaven et al. Apr 2015 A1
20150211946 Pons et al. Jul 2015 A1
20150230947 Krieger et al. Aug 2015 A1
20150257877 Hernandez Sep 2015 A1
20150257883 Basude et al. Sep 2015 A1
20150306806 Dando et al. Oct 2015 A1
20160015410 Asirvatham et al. Jan 2016 A1
20160074165 Spence et al. Mar 2016 A1
20160174979 Wei Jun 2016 A1
20170042678 Ganesan et al. Feb 2017 A1
20170100183 Iaizzo Apr 2017 A1
20170143330 Basude et al. May 2017 A1
20170202559 Taha Jul 2017 A1
20170232238 Biller et al. Aug 2017 A1
20180008268 Khairkhahan Jan 2018 A1
20180028215 Cohen Feb 2018 A1
20180092661 Prabhu Apr 2018 A1
20180133010 Kizuka May 2018 A1
20180161159 Lee et al. Jun 2018 A1
20180360457 Ellis et al. Dec 2018 A1
20190029790 Bak-Boychuk et al. Jan 2019 A1
20190183571 De Marchena Jun 2019 A1
20190298517 Sanchez et al. Oct 2019 A1
20200121460 Dale et al. Apr 2020 A1
Foreign Referenced Citations (159)
Number Date Country
1469724 Jan 2004 CN
102770080 Nov 2012 CN
103841899 Jun 2014 CN
104244841 Dec 2014 CN
3504292 Jul 1986 DE
9100873 Apr 1991 DE
10116168 Nov 2001 DE
0179562 Apr 1986 EP
0558031 Sep 1993 EP
0684012 Nov 1995 EP
0727239 Aug 1996 EP
0782836 Jul 1997 EP
1230899 Aug 2002 EP
1674040 Jun 2006 EP
1980288 Oct 2008 EP
2005912 Dec 2008 EP
2537487 Dec 2012 EP
2641570 Sep 2013 EP
2702965 Mar 2014 EP
3009103 Apr 2016 EP
2705556 Dec 1994 FR
2768324 Mar 1999 FR
2903292 Jan 2008 FR
1598111 Sep 1981 GB
2151142 Jul 1985 GB
09-253030 Sep 1997 JP
11-089937 Apr 1999 JP
2000-283130 Oct 2000 JP
2006-528911 Dec 2006 JP
2013-516244 May 2013 JP
2014-523274 Sep 2014 JP
2015-502548 Jan 2015 JP
8100668 Mar 1981 WO
9101689 Feb 1991 WO
9118881 Dec 1991 WO
9212690 Aug 1992 WO
9418881 Sep 1994 WO
9418893 Sep 1994 WO
9508292 Mar 1995 WO
9511620 May 1995 WO
9515715 Jun 1995 WO
9614032 May 1996 WO
9620655 Jul 1996 WO
9622735 Aug 1996 WO
9630072 Oct 1996 WO
9718746 May 1997 WO
9725927 Jul 1997 WO
9726034 Jul 1997 WO
9738748 Oct 1997 WO
9739688 Oct 1997 WO
9748436 Dec 1997 WO
9807375 Feb 1998 WO
9824372 Jun 1998 WO
9830153 Jul 1998 WO
9832382 Jul 1998 WO
9835638 Aug 1998 WO
9900059 Jan 1999 WO
9901377 Jan 1999 WO
9907295 Feb 1999 WO
9907354 Feb 1999 WO
9913777 Mar 1999 WO
9944524 Sep 1999 WO
9966967 Dec 1999 WO
0002489 Jan 2000 WO
0003651 Jan 2000 WO
0003759 Jan 2000 WO
0012168 Mar 2000 WO
0044313 Aug 2000 WO
0059382 Oct 2000 WO
0060995 Oct 2000 WO
0100111 Jan 2001 WO
0100114 Jan 2001 WO
0103651 Jan 2001 WO
0126557 Apr 2001 WO
0126586 Apr 2001 WO
0126587 Apr 2001 WO
0126588 Apr 2001 WO
0126703 Apr 2001 WO
0128432 Apr 2001 WO
0128455 Apr 2001 WO
0147438 Jul 2001 WO
0149213 Jul 2001 WO
0150985 Jul 2001 WO
0154618 Aug 2001 WO
0156512 Aug 2001 WO
0166001 Sep 2001 WO
0170320 Sep 2001 WO
0189440 Nov 2001 WO
0195831 Dec 2001 WO
0195832 Dec 2001 WO
0197741 Dec 2001 WO
0200099 Jan 2002 WO
0201999 Jan 2002 WO
0203892 Jan 2002 WO
0234167 May 2002 WO
0260352 Aug 2002 WO
0262263 Aug 2002 WO
0262270 Aug 2002 WO
0262408 Aug 2002 WO
0301893 Jan 2003 WO
0303930 Jan 2003 WO
0320179 Mar 2003 WO
0328558 Apr 2003 WO
0337171 May 2003 WO
0347467 Jun 2003 WO
0349619 Jun 2003 WO
0373910 Sep 2003 WO
0373913 Sep 2003 WO
0382129 Oct 2003 WO
2003105667 Dec 2003 WO
2004004607 Jan 2004 WO
2004006810 Jan 2004 WO
2004012583 Feb 2004 WO
2004012789 Feb 2004 WO
2004014282 Feb 2004 WO
2004019811 Mar 2004 WO
2004030570 Apr 2004 WO
2004037317 May 2004 WO
2004045370 Jun 2004 WO
2004045378 Jun 2004 WO
2004045463 Jun 2004 WO
2004047679 Jun 2004 WO
2004062725 Jul 2004 WO
2004082523 Sep 2004 WO
2004082538 Sep 2004 WO
2004093730 Nov 2004 WO
2004103162 Dec 2004 WO
2004112585 Dec 2004 WO
2004112651 Dec 2004 WO
2005002424 Jan 2005 WO
2005018507 Mar 2005 WO
2005027797 Mar 2005 WO
2005032421 Apr 2005 WO
2005062931 Jul 2005 WO
2005112792 Dec 2005 WO
2006037073 Apr 2006 WO
2006105008 Oct 2006 WO
2006105009 Oct 2006 WO
2006113906 Oct 2006 WO
2006115875 Nov 2006 WO
2006115876 Nov 2006 WO
2007136829 Nov 2007 WO
2008103722 Aug 2008 WO
2010024801 Mar 2010 WO
2010121076 Oct 2010 WO
2012020521 Feb 2012 WO
2013049734 Apr 2013 WO
2013103934 Jul 2013 WO
2014064694 May 2014 WO
2014121280 Aug 2014 WO
2016022797 Feb 2016 WO
2016144708 Sep 2016 WO
2016150806 Sep 2016 WO
2017223073 Dec 2017 WO
2018009718 Jan 2018 WO
2018106482 Jun 2018 WO
2018236766 Dec 2018 WO
2019040943 Feb 2019 WO
2019195336 Oct 2019 WO
Non-Patent Literature Citations (133)
Entry
Office Action received for U.S. Appl. No. 15/423,060, dated Oct. 28, 2019.
Office Action received for U.S. Appl. No. 15/642,245, dated Aug. 9, 2019.
Office Action received for U.S. Appl. No. 15/724,545, filed Dec. 27, 2019.
Office Action received for U.S. Appl. No. 15/724,545, dated Dec. 27, 2019.
Office Action received for U.S. Appl. No. 15/724,545, dated May 1, 2020.
Osawa et al., “Partial Left Ventriculectomy in a 3-Year Old Boy with Dilated Cardiomyopathy,” Japanese Journal of Thoracic and Cardiovascular Surg, 48:590-593 (2000).
Park et al., Clinical Use of Blade Atrial Septostomy, Circulation, 1978, pp. 600-608, vol. 58.
Park et al., Clinical Use of Blade Atrial Septostomy, Circulation, pp. 600-608, vol. 58, No. 4 (1978).
Patel et al., #57 Epicardial Atrial Defibrillation: Novel Treatment of Postoperative Atrial Fibrillation, 2003 STS Presentation, [Abstract Only].
Privitera et al., “Alfieri Mitral Valve Repair: Clinical Outcome and Pathology,” Circulation, 106:e173-e174 (2002).
Redaelli et al., “A Computational Study of the Hemodynamics After ‘Edge-To-Edge’ Mitral Valve Repair,” Journal of Biomechanical Engineering, 123:565-570 (2001).
Reul et al., “Mitral Valve Reconstruction for Mitral Insufficiency,” Progress in Cardiovascular Diseases, XXXIX(6):567-599 (1997).
Ricchi et al, Linear Segmental Annuloplasty for Mitral Valve Repair, Ann. Thorac. Surg., Jan. 7, 1997, pp. 1805-1806, vol. 63.
Ricchi et al., Linear Segmental Annuloplasty for Milral Valve Repair, Ann. Thorac. Surg., Jan. 7, 1997, pp. 1805-1806, vol. 63.
Robicsek et al., #60 The Bicuspid Aortic Valve: How Does It Function? Why Does It Fail? 2003 STS Presentation, [Abstract Only].
Rose et al., “Late MitraClip Failure: Removal Technique for Leaflet-Sparing Mitral Valve Repair”, Journal of Cardiac Surgery, (Jul. 4, 2012), XP055047339, DOI: 10.1111/j. 1540- 8191.2012.01483.x [retrieved on Dec. 11, 2012].
Supplemental European Search Report of EP Application No. 02746781, dated May 13, 2008, 3 pages total.
Supplementary European Search Report issued in European Application No. 05753261.6 dated Jun. 9, 2011, 3 pages total.
Tager et al, Long-Term Follow-Up of Rheumatic Patients Undergoing Left-Sided Valve Replacement With Tricuspid Annuloplasty—Validity of Preoperative Echocardiographic Criteria in the Decision to Perform Tricuspid Annuloplasty, Am. J. Cardiol., Apr. 15, 1998, pp. 1013-1016, vol. 81.
Tager et al., Long-Term Follow-Up of Rheumatic Patients Undergoing Left-Sided Valve Replacement With Tricuspid Annuloplasty—Validity of Preoperative Echocardiographic Criteria in the Decision to Perform Tricuspid Annuloplasty, Am. J. Cardiel., Apr. 15, 1998, pp. 1013-1016, vol. 81.
Takizawa H et al: Development of a microfine active bending catheter equipped with MIF tactile sensors“, Micro Electro Mechanical Systems, 1999. MEMS '99. Twelfth IEEE Interna Tional Conference on Orlando, FL, USA Jan. 17-21, 1999, Piscataway, NJ, USA,IEEE, US, Jan. 17, 1999 (Jan. 17, 1999), pp. 412-417, XP010321677, ISBN: 978-0-7803-5194-3 figures 1-3.”
Tamura et al., “Edge to Edge Repair for Mitral Regurgitation in a Patient with Chronic Hemodialysis: Report of a Case,” Kyobu Geka. The Japanese Journal of Thoracic Surgery, 54(9):788-790 (2001).
Tibayan et al., #59 Annular Geometric Remodeling in Chronic Ischemic Mitral Regurgitation, 2003 STS Presentation, [Abstract Only].
Timek et al., “Edge-to-edge mitral repair: gradients and three-dimensional annular dynamics in vivo during inotropic stimulation,” Eur J. of Cardiothoracic Surg., 19:431-437 (2001).
Timek, “Edge-to-Edge Mitral Valve Repair without Annuloplasty Ring in Acute Ischemic Mitral Regurgitation,” [Abstract] Clinical Science, Abstracts from Scientific Sessions, 106(19):2281 (2002).
Totaro, “Mitral valve repair for isolated prolapse of the anterior leaflet: an 11-year follow-up,” European Journal of Cardio-thoracic Surgery, 15:119-126 (1999).
U.S. Provisional Application filed Jul. 6, 2016, by Khairkhahan., U.S. Appl. No. 62/359,121.
U.S. Provisional Application filed Nov. 7, 2016, by Khairkhahan., U.S. Appl. No. 62/418,571.
U.S. Provisional Application filed Oct. 22, 2018, by Dale et al., U.S. Appl. No. 62/748,947.
Uchida et al, Percutaneous Cardiomyotomy and Valvulotomy with Angioscopic Guidance, Am. Heart J., Apr. 1991, pp. 1221-1224, vol. 121.
Uchida et al., Percutaneous Cardiomyotomy and Valvulotomy with Angioscopic Guidance, Am. Heart J., pp. 1221-1224, vol. 121 (Apr. 1991).
Umana et al, ‘Bow-Tie’ Mitral Valve Repair: An Adjuvant Technique for Ischemic Mitral Regurgitation, Ann. Thorac. Surg., May 12, 1998, pp. 1640-1646, vol. 66.
Umana et al., “‘Bow-tie’ Mitral Valve Repair Successfully Addresses Subvalvular Dysfunction in Ischemic Mitral Regurgitation,” Surgical Forum, XLVI11:279-280 (1997).
U.S. Appl. No. 14/216,813, filed Mar. 17, 2014, Hernandez.
Votta et al., “3-D Computational Analysis of the Stress Distribution on the Leaflets after Edge-to-Edge Repair of Mitral Regurgitation,” Journal of Heart Valve Disease, 11:810-822 (2002).
Abe et al, “De Vega's Annuloplasty for Acquired Tricuspid Disease: Early and Late Results in 110 Patients”, Ann. Thorac. Surg., pp. 670-676, vol. 48 (Jan. 1989).
Abe et al., “Updated in 1996—De Vega's Annuloplasty for Acquired Tricuspid Disease: Early and Late Results in 110 Patients”, Ann. Thorac. Surg., pp. 1876-1877, vol. 62 (1996).
Agricola et al., “Mitral Valve Reserve in Double Orifice Technique: an Exercise Echocardiographic Study,” Journal of Heart Valve Disease, 11(5):637-643 (2002).
Alfieri et al., “An Effective Technique to Correct Anterior Mitral Leaflet Prolapse,” J. Card Surg., 14:468-470 (1999).
Alfieri et al., “Novel Suture Device for Beating Heart Mitral Leaflet Approximation,” Annals of Thoracic Surgery, 74:1488-1493 (2002).
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic and Cardiovascular Surgery, 122:674-681 (2001).
Alfieri et al., “The Edge to Edge Technique,” The European Association For Cardio—Thoracic Surgery, 14th Annual Meeting, Frankfurt/ Germany, Oct. 7-11, 2000, Post Graduate Courses, Book of Proceedings.
Alfieri, “The Edge-to-Edge Repair of the Mitral Valve,” [Abstract] 6th Annual New Era Cardiac Care: Innovation & Technology, Heart Surgery Forum, (Jan. 2003) pp. 103.
Ali Khan et al, Blade Atrial Septostomy: Experience with the First 50 Procedures, Cathet. Cardiovasc. Diagn., Aug. 1991, pp. 257-262, vol. 23.
Alvarez et al, Repairing the Degenerative Mitral Valve: Ten to Fifteen-year Follow-up, Journal of Thoracic Cardiovascular Surgery, Aug. 1996, pp. 238-247, vol. 112, No. 2.
Alvarez et al, Repairing the Degenerative Mitral Valve: Ten to Fifteen-year Follow-up, Journal Thoracic of Cardiovascular Surgery, Aug. 1996, pp. 238-247, vol. 112, No. 2.
Arisi et al., “Mitral Valve Repair with Alfieri Technique in Mitral Regurgitation of Diverse Etiology: Early Echocardiographic Results,” Circulation Supplement II, 104(17):3240 (2001).
Bach et al, Early Improvement in Congestive Heart Failure After Correction of Secondary Mitral Regurgitation in End-stage Cardiomyopathy, American Heart Journal, Jun. 1995, pp. 1165-1170, vol. 129, No. 6.
Bach et al, Improvement Following Correction of Secondary Mitral Regurgitation in End-stage Cardiomyopathy With Mitral Annuloplasty, Am. J. Cardiol., Oct. 15, 1996, pp. 966-969, vol. 78.
Bach et al, Improvement Following Correction of Secondary Mitral Regurgitation in End-stage Cardiomyopathy With Mitral Annuloplasty, Am J_ Cardiel., Oct. 15, 1996, pp. 966-969, vol. 78.
Bailey, “Mitral Regurgitation” in Surgery of the Heart, Chapter 20, pp. 686-737 (1955).
Bernal et al., “The Valve Racket: a new and different concept of atrioventricular valve repair,” Eur. J. Cardio-thoracic Surgery 29:1026-1029 (2006).
Bhudia et al., “Edge-to-Edge (Alfieri) Mitral Repair: Results in Diverse Clinical Settings,” Ann Thorac Surg, 77:1598-1606 (2004).
Bhudia, #58 Edge-to-edge mitral repair: a versatile mitral repair technique, 2003 STS Presentation, [Abstract Only], 2004.
Bolling et al, Surgery for Acquired Heart Disease: Early Outcome of Mitral Valve Reconstruction in Patients with End-stage Cardiomyopathy, Journal of Thoracic and Cariovascular Surgery, Apr. 1995, pp. 676-683, vol. 109, No. 4.
Borghetti et al., “Preliminary observations on haemodynamics during physiological stress conditions following ‘double-orifice’ mitral valve repair,” European Journal of Cardio-thoracic Surgery, 20:262-269 (2001).
Castedo, “Edge-to-Edge Tricuspid Repair for Redeveloped Valve Incompetence after DeVega's Annuloplasty,” Ann Thora Surg., 75:605-606 (2003).
Chinese Office Action issued in Chinese Application No. 200980158707.2 dated Sep. 9, 2013.
Communication dated Apr. 16, 2018 from the European Patent Office in counterpart European application No. 04752603.3.
Communication dated Apr. 28, 2017 issued by the European Patent Office in counterpart application No. 16196023.2.
Communication dated Jan. 26, 2017, from the European Patent Office in counterpart European application No. 16196023.2.
Communication dated May 8, 2017, from the European Patent Office in counterpart European Application No. 04752714.8.
Dang N C et al., “Surgical Revision After Percutaneous Mitral Valve Repair with a Clip: Initial Multicenter Experience”,THE Annals of Thracic SURGERY,Elsevier, United States, vol. 80, No. 6, pp. 2338-2342, (Dec. 1, 2005), XP027732951, ISSN:0003-4975 [retrieved on Dec. 1, 2005].
Dec et al, Idiopathic Dilated Cardiomyopathy, The New England Journal of Medicine, Dec. 8, 1994, pp. 1564-1575, vol. 331, No. 23.
Dottori et al., “Echocardiographic imaging of the Alfieri type mitral valve repair,” Itai. Heart J., 2(4):319-320 (2001).
Downing et al., “Beating heart mitral valve surgery: Preliminary model and methodology,” Journal of Thoracic and Cardiovascular Surgery, 123(6):1141-1146 (2002).
Extended European Search Report, dated Oct. 17, 2014, issued in European Patent Application No. 06751584.1.
Falk et al., “Computer-Enhanced Mitral Valve Surgery: Toward a Total Endoscopic Procedure,” Seminars in Thoracic and Cardiovascular Surgery, 11(3):244-249 (1999).
Feldman, et al. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of Everest II. J Am Coll Cardiol. Dec. 29, 2015;66(25):2844-2854.
Filsoufi et al., “Restoring Optimal Surface of Coaptation With a Mini Leaflet Prosthesis: A New Surgical Concept for the Correction of Mitral Valve Prolapse,” Intl. Soc. for Minimally Invasive Cardiothoracic Surgery 1(4):186-87 (2006).
Frazier et al., #62 Early Clinical Experience with an Implantable, Intracardiac Circulatory Support Device: Operative Considerations and Physiologic Implications, 2003 STS Presentation, 1 page total. [Abstract Only].
Fucci et al, Improved Results with Mitral Valve Repair Using New Surgical Techniques, Eur. J. Cardiothorac. Surg., Nov. 1995, pp. 621-627, vol. 9.
Fundaro et al., “Chordal Plication and Free Edge Remodeling for Mitral Anterior Leaflet Prolapse Repair: 8-Year Follow-up,” Annals of Thoracic Surgery, 72:1515-1519 (2001).
Garcia-Rinaldi et al., “Left Ventricular Volume Reduction and Reconstruction is Ischemic Cardiomyopathy,” Journal of Cardiac Surgery, 14:199-210 (1999).
Gateliene, “Early and postoperative results results of metal and tricuspid valve insufficiency surgical treatment using edge-to-edge central coaptation procedure,” (Oct. 2002) 38 (Suppl 2):172 175.
Gatti et al., “The edge to edge technique as a trick to rescue an imperfect mitral valve repair,” Eur. J. Cardiothorac Surg, 22:817-820 (2002).
Gundry, “Facile mitral valve repair utilizing leaflet edge approximation: midterm results of the Alfieri figure of eight repair,” Presented at the Meeting of the Western Thoracic Surgical Association, (1999).
Gupta et al., #61 Influence of Older Donor Grafts on Heart Transplant Survival: Lack of Recipient Effects, 2003 STS Presentation, [Abstract Only].
Ikeda et al., “Batista's Operation with Coronary Artery Bypass Grafting and Mitral Valve Plasty for Ischemic Dilated Cardiomyopathy,” The Japanese Journal of Thoracic and Cardiovascular Surgery, 48:746-749 (2000).
Izzat et al., “Early Experience with Partial Left Ventriculectomy in the Asia-Pacific Region,” Annuals of Thoracic Surgery, 67:1703-1707 (1999).
Kallner et al., “Transaortic Approach for the Alfieri Stitch,” Ann Thorac Surg, 71:378-380 (2001).
Kameda et al, Annuloplasty for Severe Milral Regurgitation Due to Dilated Cardiomyopathy, Ann. Thorac. Surg., 1996, pp. 1829-1832, vol. 61.
Kameda et al, Annuloplasty for Severe Mitral Regurgitation Due to Dilated Cardiomyopathy, Ann. Thorac. Surg., 1996, pp. 1829-1832, vol. 61.
Kavarana et al., “Transaortic Repair of Mitral Regurgitation,” The Heart Surgery Forum, #2000-2389, 3(1):24-28 (2000).
Kaza et al., “Ventricular Reconstruction Results in Improved Left Ventricular Function and Amelioration of Mitral Insufficiency,” Annals of Surgery, 235(6):828-832 (2002).
Khan et al., “Blade Atrial Septostomy; Experience with the First 50 Procedures”, Catheterization and Cardiovascular Diagnosis, 23:257-262 (1991).
Kherani et al., “The Edge-To-Edge Mitral Valve Repair: The Columbia Presbyterian Experience,” Ann. Thorac. Surg., 78:73-76 (2004).
Kron et al., “Surgical Relocation of the Posterior Papillary Muscle in Chronic Ischemic Mitral Regurgitation,” Annals. of Thoracic Surgery, 74:600-601 (2002).
Kruger et al., “P73-Edge to Edge Technique in Complex Mitral Valve Repair,” Thorac Cardiovasc Surg., 48(Suppl. 1):106 (2000).
Langer et al., “Posterier mitral leaflet extensions: An adjunctive repair option for ischemic mitral regurgitation?” J Thorac Cardiovasc Surg, 131:868-877 (2006).
Lorusso et al., “The double-orifice technique for mitral valve reconstruction: predictors of postoperative outcome,” Eur J. Cardiothorac Surg, 20:583-589 (2001).
Maisano et al., The Edge-to-edge Technique: A Simplified Method to Correct Mitral Insufficiency, Eur. J. Cardiothorac. Surg , Jan. 14, 1998, pp. 240-246, vol. 13.
Maisano et al., The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. Jul. 7, 2015; 36(26):1651-1659.
Maisano et al., “The double orifice repair for Barlow Disease: a simple solution for a complex repair,” Supplement in Circulation, (Nov. 1999); 100(18):1-94.
Maisano et al.,“The double orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique,” European Journal of Cardio-thoracic Surgery, 17:201-205 (2000).
Maisano et al., “The Future of Transcatheter Mitral Valve Interventions: Competitive or Complementary Role of Repair vs. Replacement?”, Eur Heart J.36(26):1651-1659 (Jul. 7, 2015).
Maisano et al.,“The hemodynamic effects of double-orifice valve repair for mitral regurgitation: a 3D computational model,” European Journal of Cardio-thoracic Surgery, 15:419-425 (1999).
Maisano et al., “Valve repair for traumatic tricuspid regurgitation,” Eur. J. Cardio-thorac Surg, (1996) 10:867-873.
Maisano et al., 'The Edge-to-edge Technique: A Simplified Method to Correct Mitral Insufficiency, Eur. J. Cardiothorac. Surg., pp. 240-246, vol. 13 (Jan. 14, 1998).
Mantovani et al., “Edge-to-edge Repair of Congenital Familiar Tricuspid Regurgitation: Case Report,” J. Heart Valve Dis., 9:641-643 (2000).
McCarthy et al, “Tricuspid Valve Repair With the Cosgrove-Edwards Annuloplasty System”, Ann. Thorac. Surg., 64:267-8 ( Jan. 16, 1997).
McCarthy et al., “Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure,” European Journal of Cardio-thoracic Surgery, 13:337-343 (1998).
McCarthy et al., “Tricuspid Valve Repair With the Cosgrove-Edwards Annuloplasty System”, Ann. Throac Surg. 64:267-8 (Jan. 16, 1997).
Moainie et al., “Correction of Traumatic Tricuspid Regurgitation Using the Double Orifice Technique,” Annals of Thoracic Surgery, 73:963-965 (2002).
Morales et al., “Development of an Off Bypass Mitral Valve Repair,” The Heart Surgery Forum #1999-4693, 2(2):115-120 (1999).
Nakanishi et al., “Early Outcome with the Alfieri Mitral Valve Repair,” J. Cardiol., 37: 263-266 (2001) [Abstract in English; Article in Japanese].
Nielsen et al., “Edge-to-Edge Mitral Repair: Tension of the Approximating Suture and Leaflet Deformation During Acute Ischemic Mitral Regurgitation in the Ovine Heart,” Circulation, 104(Suppl. 1):1-29-1-35 (2001).
Nishimura, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. Jun. 10, 2014;63(22):2438-88.
Noera et al., “Tricuspid Valve Incompetence Caused by Nonpenetrating Thoracic Trauma”, Annals of Thoracic Surgery, 51:320-322 (1991).
Notice of Allowance received for U.S. Appl. No. 14/216,787, filed Nov. 7, 2016.
Notice of Allowance received for U.S. Appl. No. 14/216,787, dated Nov. 7, 2016.
Notice of Allowance received for U.S. Appl. No. 14/577,852, filed Apr. 25, 2018.
Notice of Allowance received for U.S. Appl. No. 14/577,852, dated Apr. 25, 2018.
Notice of Allowance received for U.S. Appl. No. 15/642,245, dated Jan. 29, 2020.
Notice of Allowance received for U.S. Appl. No. 15/642,245, dated Mar. 27, 2020.
Notice of Allowance received for U.S. Appl. No. 15/642,245, dated Nov. 6, 2019.
Notice of Allowance received for U.S. Appl. No. 15/423,060, dated Jan. 27, 2020.
Office Action received for U.S. Appl. No. 14/216,787, filed Apr. 8, 2016.
Office Action received for U.S. Appl. No. 14/216,787, dated Apr. 8, 2016.
Office Action received for U.S. Appl. No. 14/216,813, filed Apr. 6, 2018.
Office Action received for U.S. Appl. No. 14/216,813, filed Dec. 15, 2017.
Office Action received for U.S. Appl. No. 14/216,813, filed Mar. 9, 2017.
Office Action received for U.S. Appl. No. 14/216,813, dated Apr. 6, 2018.
Office Action received for U.S. Appl. No. 14/216,813, dated Dec. 15, 2017.
Office Action received for U.S. Appl. No. 14/216,813, dated Mar. 9, 2017.
Office Action received for U.S. Appl. No. 14/577,852, filed May 16, 2017.
Office Action received for U.S. Appl. No. 14/577,852, filed Oct. 20, 2016.
Office Action received for U.S. Appl. No. 14/577,852, filed Sep. 7, 2017.
Office Action received for U.S. Appl. No. 14/577,852, dated May 16, 2017.
Office Action received for U.S. Appl. No. 14/577,852, dated Oct. 20, 2016.
Office Action received for U.S. Appl. No. 14/577,852, dated Sep. 7, 2017.
Office Action received for U.S. Appl. No. 15/423,060, dated Apr. 25, 2019.
Office Action received for U.S. Appl. No. 15/423,060, dated Aug. 19, 2019.
Related Publications (1)
Number Date Country
20220008096 A1 Jan 2022 US
Provisional Applications (1)
Number Date Country
62404558 Oct 2016 US
Divisions (1)
Number Date Country
Parent 15724545 Oct 2017 US
Child 17382606 US